Archives

The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA

B CHENGDU, China, May 8, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech” or the “Company”) announced that the sNDA (the “Application”) for the… Login to continue reading Login…

Read MoreThe sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA

TOOTOO Self-Develops Ultra-Olaflur, Achieving a New Breakthrough in Super Cavity Protection for Children’s Toothpaste

B Acid erosion resistance increased by 5 times, remineralization effect 1.7 times higher than previous generation Olaflur HANGZHOU, China, May 8, 2026 /PRNewswire/ — Recently,… Login to continue reading Login…

Read MoreTOOTOO Self-Develops Ultra-Olaflur, Achieving a New Breakthrough in Super Cavity Protection for Children’s Toothpaste

A new device for pre-clinical cancer research: KUBTEC® Scientific redefines image-guided radiotherapy with The XCELL® TomoRad™ x-ray irradiator

B STRATFORD, Conn., May 8, 2026 /PRNewswire/ — KUBTEC®, a global leader in X-ray imaging and irradiation technology, has proudly launched the XCELL® TomoRad™ system at this year’s… Login to continue reading Login…

Read MoreA new device for pre-clinical cancer research: KUBTEC® Scientific redefines image-guided radiotherapy with The XCELL® TomoRad™ x-ray irradiator

Online Lender Loanz Doubles Down on Canada Following Strategic Restructure Driven by Consumer Demand and Market Conditions

B Responding to shifting consumer demand and a challenging US lending environment, Loanz has strategically realigned its operations toward Canada, relaunching with a rebuilt platform,… Login to continue reading Login…

Read MoreOnline Lender Loanz Doubles Down on Canada Following Strategic Restructure Driven by Consumer Demand and Market Conditions